The global prevalence of diabetes continues to rise. The latest estimates indicate that one in ten persons worldwide will have diabetes by 2035 [1]. It is well known that the associated cardiovascular disease represents the most prevalent cause of mortality and morbidity in this people. The improvement of cardiovascular risk factors is crucial. Particularly obesity indicated by the World Health Organization (WHO) as “the global epidemic” represents one of the leading causes of morbidity and premature mortality in industrialized countries [2].
